CJ HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CJ HealthCare Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11250
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CJ HealthCare Corp (CJ HealthCare), a subsidiary CJ CheilJedang Corp, is a provider of active pharmaceutical ingredients, OTC drugs and pharmaceutical medicines. The company’s portfolio includes biologicals, antibiotics, anti cancer, parenteral nutrition, total parenteral nutrition products. CJ HealthCare offers APIs such as cefozopran, cefmenoxime and cefotiam. The company provides OTC drugs such as CJ condition, hongsamjin gold, hutgaesoo, mach max, roboca poli, sankle eye drops and solar vita. It conducts research and development of new drugs for treatment of digestive, cancers, gastrointestinal conditions, inflammatory diseases. The company has production facilities in Osong and Daeso; Korea. It has operations in China, Germany, Japan, South Korea and Vietnam. CJ HealthCare is headquartered in Seoul, South Korea.

CJ HealthCare Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CJ HealthCare Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CJ HealthCare Enters into Co-development Agreement with ANRT 10
Licensing Agreements 11
YL Biologics Enters into Licensing Agreement with CJ HealthCare 11
Shandong Luoxin Pharma Enters into Licensing Agreement with CJ HealthCare for CJ-12420 12
Acquisition 13
Kolmar Korea to Acquire CJ HealthCare from CJ CheilJedang for USD1.17 Billion 13
CJ HealthCare Corp – Key Competitors 14
CJ HealthCare Corp – Key Employees 15
CJ HealthCare Corp – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Other Significant Developments 17
Aug 22, 2017: CJ Healthcare spurs to develop first-in class drugs based on R & D capabilities 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Key Facts 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CJ HealthCare Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CJ HealthCare Corp, Deals By Therapy Area, 2012 to YTD 2018 8
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CJ HealthCare Enters into Co-development Agreement with ANRT 10
YL Biologics Enters into Licensing Agreement with CJ HealthCare 11
Shandong Luoxin Pharma Enters into Licensing Agreement with CJ HealthCare for CJ-12420 12
Kolmar Korea to Acquire CJ HealthCare from CJ CheilJedang for USD1.17 Billion 13
CJ HealthCare Corp, Key Competitors 14
CJ HealthCare Corp, Key Employees 15
CJ HealthCare Corp, Other Locations 16
CJ HealthCare Corp, Subsidiaries 16

List of Figures
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CJ HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CJ HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • John Menzies Plc
    John Menzies Plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Protalex Inc (PRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • ENN Energy Holdings Ltd (2688):石油・ガス:M&Aディール及び事業提携情報
    Summary ENN Energy Holdings Ltd (ENN) is a clean energy distributor that offers sales and distribution of piped gas, LNG and other energy products. The company conducts investment, operation and management of gas pipeline infrastructure, wholesale of gas, the sales, distribution of piped gas and oth …
  • Chubu Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Chubu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Bioderm Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bioderm Inc (Bioderm) is a medical equipment company that manufactures designs, and markets hydrocolloid products. The company manufactures hydrocolloid products for urinary management, securement, infection control, and skin protection. Its products include cathgrip, bioplus+, freederm, men …
  • Star Group LP (SGU):企業の財務・戦略的SWOT分析
    Summary Star Group LP (Star Group) formerly Star Gas Partners LP, is a distributor of home heating products and services. The company distributes and sells heating and air conditioning equipment, diesel fuel, gasoline, propane, and home heating oil. Star Group offers home security and plumbing, inst …
  • Aduro BioTech Inc (ADRO):企業の財務・戦略的SWOT分析
    Aduro BioTech Inc (ADRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bashneft (BANE):企業の財務・戦略的SWOT分析
    Bashneft (BANE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Perrigo Company Plc (PRGO):医療機器:M&Aディール及び事業提携情報
    Summary Perrigo Company plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic and prescription pharmaceuticals, specialty pharmaceutical company, nutritional products, active pharmaceutic …
  • Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate, entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for t …
  • SEEK Limited:企業のM&A・事業提携・投資動向
    SEEK Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SEEK Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • General Dynamics Information Technology, Inc.:企業の戦略・SWOT・財務情報
    General Dynamics Information Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Information Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Northwest Territories Power Corp:企業の発電所・SWOT分析2018
    Northwest Territories Power Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Breeze-Eastern Corporation:企業の戦略・SWOT・財務情報
    Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report Summary Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Kawasumi Laboratories Inc (7703):企業の財務・戦略的SWOT分析
    Summary Kawasumi Laboratories Inc (Kawasumi) is a medical device company that manufactures and distributes disposable blood collection and transfusion sets. The company’s product portfolio includes hemodialysis, plasmapheresis, blood banking and transfusion, infusion therapy, andendovascular repair …
  • PT Rekayasa Industri:企業の戦略的SWOT分析
    PT Rekayasa Industri - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Precision Optics Corporation Inc (PEYE)-医療機器分野:企業M&A・提携分析
    Summary Precision Optics Corporation Inc (Precision Optics) is a medical device company that designs, develops, manufactures and distributes optics and optical systems for medical, biomedical, and industrial applications. The company offers custom optics solutions such as design and prototyping, fib …
  • Tragara Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tragara Pharmaceuticals Inc (Tragara Pharmaceuticals) is a pharmaceutical company focused on the clinical and commercial development of its proprietary medicines for the treatment of various cancers. Its lead product candidate TG02, an oral multi-kinase inhibitor facilitates anti-tumor activ …
  • Centrica plc:企業の戦略・SWOT・財務情報
    Centrica plc - Strategy, SWOT and Corporate Finance Report Summary Centrica plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • LEM Holding SA (LEHN):企業の財務・戦略的SWOT分析
    LEM Holding SA (LEHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆